Project Grant K22AG093185
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded the University of Nebraska Medical Center $644,298 under the Aging Research program (CFDA 93.866) on February 1, 2026, with a completion date of January 31, 2031. This project grant supports research into next-generation treatments for peripheral artery disease (PAD), a progressive vascular condition affecting the lower extremities. The research will develop and validate regenerative, cell-based therapeutic...
- Federal Grant Award Summary The National Institute on Aging awarded a $698,690 Project Grant to the University of Wisconsin-Madison, effective February 1, 2026 through January 31, 2031, under the Aging Research program (CFDA 93.866). This award supports comprehensive scientific research investigating the molecular mechanisms of fiber type-specific skeletal muscle dysfunction during human aging. The research aims to elucidate how aging differentially affects slow versus fast skeletal muscle...
- Federal Project Grant Award Summary Panorama Research Incorporated received a $354,000 Project Grant from the National Institute on Aging (Aging Research program, CFDA 93.866) awarded on September 20, 2025, with a completion date of September 19, 2026. The award funds the development of a novel therapeutic approach to address sarcopenia, characterized by age-related loss of skeletal muscle mass, quality, and strength. The research focuses on engineering extended half-life variants of Isthmin 1...
- Federal Project Grant Award Summary Rowan University received a $530,469 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective August 15, 2025, with a completion date of July 31, 2028. The award funds biomedical research investigating the role of orosomucoid1 in skeletal muscle aging and sarcopenia (age-related loss of muscle mass and function). The research employs a proteomic analysis approach to elucidate the molecular...
- Federal Project Grant Award Summary Augusta University Research Institute, Inc. (AURI) received a $542,699 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective January 1, 2026 through December 31, 2030. The award funds biomedical research investigating epigenetic mechanisms underlying the selective vulnerability of parvalbumin-positive neurons in the entorhinal cortex during aging and Alzheimer's disease (AD) progression. The research...
- Federal Project Grant Award Summary The University of Nebraska, through its Office of Sponsored Programs, received a $198,263 Project Grant award dated September 5, 2025, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award funds basic science research investigating the role of Mitsugumin 53 (MG53) in preventing disuse-induced muscle atrophy, with a project...
- Federal Project Grant Award Summary The University of Michigan, through its Office of Research and Sponsored Projects, received a $2.99 million Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) to conduct comprehensive scientific research on reactive oxygen species (ROS) as early-life modulators of lifespan and aging. Funded from September 1, 2025, through August 31, 2029, this research initiative will investigate the mechanisms...
- Federal Project Grant Award Summary The University of Rhode Island Research Office received a $567,224 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective February 1, 2026, through January 31, 2031. This five-year research initiative investigates tissue-specific modulation of mitochondrial DNA (mtDNA) mutations to advance understanding of aging and age-related diseases. The project employs novel genetic approaches and...
- Federal Grant Award Summary The University of Missouri System received a $429,394 Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866) effective December 15, 2025, with completion targeted for November 30, 2027. This award funds research investigating LARP6 (LA Ribonucleoprotein 6) as a potential therapeutic target for age-associated heart failure with preserved ejection fraction (HFpEF)—a condition characterized by cardiac fibrosis and...
- Federal Project Grant Award Summary Duke University's Office of Research Administration is conducting a five-year research project funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), with $493,972 obligated for the project period spanning January 1, 2026, through December 31, 2030. The project, titled "Cell Type-Specific Epitranscriptomic Regulation in the Brain in Aging and Alzheimer's Disease," focuses on understanding how adenosine methylation...
Auburn University received a $166,152 Project Grant from the National Institute on Aging (Aging Research Program, CFDA 93.866) effective March 1, 2026, through February 28, 2029. This award supports biomedical research directed toward understanding the role of microRNA-1 (miR-1) in regulating pyruvate metabolism and skeletal muscle metabolic dysfunction in patients with peripheral artery disease (PAD). The research will deliver scientific investigation into how miR-1 and its target genes contribute to skeletal muscle metabolic myopathy and mobility limitation in both experimental PAD models and clinical disease. Primary deliverables include identification of the miR-1-regulated transcriptome, determination of mechanisms by which miR-1 loss contributes to metabolic inflexibility, and evaluation of whether rescuing skeletal muscle miR-1 expression can ameliorate ischemic pathology and exercise-induced metabolic function. The research employs state-of-the-art experimental approaches including Argonaute enhanced crosslinking and immunoprecipitation coupled with high-throughput sequencing (eCLIP-seq) to characterize molecular mechanisms and will utilize genetically modified mouse models alongside clinical disease samples. These research outputs are intended to generate evidence supporting the development of therapeutic interventions targeting skeletal muscle metabolic pathways in PAD, a condition affecting an estimated 8-12 million Americans, including 10-15% of individuals age 65 and older. The three-year project period aligns with standard National Institute on Aging grant parameters supporting biomedical and behavioral research training in aging-related conditions.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $166.2k | 2/27/26 |